Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea flag South Korea · Delayed Price · Currency is KRW
27,200
-1,900 (-6.53%)
At close: Oct 2, 2025
-6.53%
Market Cap857.02B
Revenue (ttm)586.15B
Net Income (ttm)-2.48B
Shares Out31.51M
EPS (ttm)-88.84
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,995,903
Average Volume4,421,947
Open28,800
Previous Close29,100
Day's Range26,950 - 29,350
52-Week Range10,300 - 34,700
Beta1.16
RSI52.89
Earnings DateNov 12, 2025

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system... [Read more]

Sector Healthcare
Founded 1941
Employees 1,067
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

In 2024, Ildong Pharmaceutical's revenue was 614.94 billion, an increase of 2.36% compared to the previous year's 600.76 billion. Losses were -4.58 billion, -94.20% less than in 2023.

Financial Statements

News

There is no news available yet.